Feist, Eugen <br/><br/>
Canakinumab for treatment of cryopyrin-associated periodic syndrome.  [electronic resource] 

 -  Expert opinion on biological therapy  Nov 2010 
 - 1631-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.2010.530653  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute-Phase Reaction<br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Child<br/>Child, Preschool<br/>Clinical Trials, Phase II as Topic--statistics & numerical data<br/>Cryopyrin-Associated Periodic Syndromes--epidemiology<br/>Double-Blind Method<br/>Humans<br/>Inflammation<br/>Interleukin-1beta--antagonists & inhibitors<br/>Multicenter Studies as Topic--statistics & numerical data<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Treatment Outcome